Background: Baicalein, a bioactive flavonoid was explored for its capability to attenuate sevoflurane induced neuronal apoptosis and to improve behavioural and cognitive impairments. Sevoflurane is a frequently used inhalation anesthetic in neonates and children. Neonatal sevoflurane exposure causes widespread neurodegeneration and cognitive impairments. Development of compounds that could effectively prevent/ reduce the adverse effects is of tremendous medical value. Methods: Isolated groups of neonatal rats were regulated with baicalein (25, 50 or 100 mg/kg b.wt) from postnatal day 3 (P3) to P21 and were exposed to sevoflurane (3%; 6 h) on P7. Results: Baicalein inhibited sevoflurane induced neuroapoptosis significantly as assessed by TUNEL assay. The raised levels of cleaved caspase-3, Bad and Bax were down-regulated by baicalein with enhanced Bcl-2, Bcl-xL, xIAP, c-IAP-1, c-IAP-2 and survivin expression. Baicalein regulated JNK/ERK signalling and also activated the PI3K/Akt pathway effectively as evident from the increased Akt, phospho-Akt, GSK-3β, phospho-GSK-3β levels. Baicalein, also improved the behaviour of animals in open filed and olfactory tests. The freezing responses and the performance in Morris Water Maze tests were enhanced. Conclusion: Baicalein reduced neurodegeneration and improved learning and memory retention of rats and as well modulated PI3/ Akt/GSK-3β and JNK/ERK signalling pathways.
Introduction
Anesthetics are inevitable part of therapeutic care that demands surgery and related procedures. Inhalational anesthetics such as sevoflurane are most commonly used for general anesthesia, especially in pediatric patients [1] . However, accumulating experimental data on anesthetic-induced neurotoxicity have raised stern concerns on the safety of drugs [2] [3] [4] . General anesthetics have been stated to induce neuroapoptosis and potentially disturb neurogenesis [5] and subsequently cause memory deficits and longterm neurocognitive dysfunctions specifically in developing brains [6] .
However, the precise mechanism underlying anesthetic-induced neurodegeneration is yet to be completely understood. Previous studies have proposed the involvement of reactive oxygen species, neuroinflammation, mitochondrial dysfunction and neurotransmitter disturbances [7] .
The phosphoinositide 3-kinase (PI3K)/ protein kinase B (Akt) pathway is expressed extensively in the CNS during development. In the neurons, PI3K is effectively induced by many growth factors including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3, as well as cytokines and neurotransmitters. PI3K/Akt pathways crucially regulate cell survival and apoptosis [8] . Further, the mitogen activated protein kinase (MAPK) signalling is been reported to be critically involved in nervous system development [9] and neurodegeneration [10] . Previous studies have shown MAPKs -JNK and ERK1/2 in isoflurane and sevoflurane-induced neurotoxicity [11] . There is also a potential interlink and crosstalk between Akt and JNK signalling pathways [11] . Targeting these pathways could possibly aid in preventing/ treating anesthetic-induced neurotoxicity and neurocognitive dysfunctions.
Many phytochemicals exhibit neuroprotective effects [12] . 5, 6, 7-trihydroxy-2-phenyl-4H-1-benzopyran-4-one, Baicalein is one of the key flavonoid of Scutellaria baicalensis that is been widely used for long time in Chinese and Japanese medicine. Antiviral, anti-hepatotoxicity, anti-inflammatory, neuroprotective have been reported [13] as bioactive effects of baicalein. Herbal preparations of baicalein have been shown to potentiate learning and memory [14] .
Wang et al. [15] reported that pre-treatment with baicalein attenuated β-amyloid peptide induced-amnesia. In this study baicalein was explored for its capability to protect brain cells against sevoflurane-induced neurotoxicity and improve cognition and memory in neonatal rats.
Materials and methods

Study design flow chart Animals
Pregnant Sprague-Dawley rats were procured from North Sichuan Medical College animal care centre for laboratory animals and were maintained under normal conditions (22 ± 1°C; 12-h light/dark cycle) in sterile cages.
The rats were provided access to water and were fed on standard pelleted diet and closely monitored for the birth of pups and day of birth was recorded as P0 (post-natal day 0).
The pups were carefully monitored and were provided free access to water and pellet food. were used for expression analysis. Other chemicals that were used in this study were of analytical grade and were purchased from Sigma-Aldrich, St.Louis, MO, USA otherwise are mentioned.
Anesthetic exposure and dosing
Baicalein (25, 50 or 100 mg/kg b.wt) was administered to isolated groups of rat pups from day P3 and continued till P21 with standard pelleted diet. On P7, pups measuring about 16-20 g of weight were exposed to sevoflurane (3%) for 6 h in 60% oxygen or air in a temperature-controlled chamber (33 -35°C) [16] . P7 rats were preferred based on earlier studies which suggested that the 1 st week after birth is equivalent to the rapid period of brain development in humans which is from 3 rd trimester to approximately 2 to 3 years. During this period of rapid brain development, neurogenesis is utmost susceptible to anesthesia-induced neuronal damages [2, 17] . Control group received no anesthesia or baicalein. After 6 h of anesthetic exposure, rat pups of each group (n = 6) were sacrificed and brain tissues were excised and used for assessment of apoptosis and for protein expression analysis by western blotting.
Separate groups of rats (n=12/group) were treated with 50 mg or 100 mg baicalein day P3 and continued till P21 along with standard pellet. The baicalein alone treated rats were not exposed to anesthetic. The rat pups exposed to sevoflurane and not treated with baicalein served as anesthetic control pups.
Analysis of neuroapoptosis -TUNEL fluorescent assay 
Behavioural analysis and memory assessment
Several studies have reported sevoflurane exposure induced cognitive dysfunctions and memory impairments [2, 3] . Here a series of tests were conducted to assess the effects of baicalein on the behaviour, memory retention and learning capacity of the rats following sevoflurane exposure.
Open field test P42 rats that were exposed to sevoflurane on post-natal day 7 (P7) were assessed for their emotional responses to a novel field. As 
Olfactory test
On post natal day 42 (P42), the rats were familiarized to the flavour of a novel food (garlic cheese) for 3 days. On fourth day the rats were subjected to fasting for 24 h and on the fifth day a portion of garlic cheese was hidden (4 cm) under bedding in a fresh cage. The animals were positioned in the cage and time taken by the rats to find the food was observed.
Morris water maze test
The Morris water maze (Shanghai Jiliang Software Technology Co. Ltd., China) was used to assess learning and memory of rats [22] . The rat pups that were exposed to sevoflurane on postnatal day 7 (P7) and/ or administered baicalein 
Baicalein improved the general behaviour and memory of rats
Behavioural responses of the study rats in a novel environment were observed.
Sevoflurane-alone administered pups did not exhibit changes in behaviour; however, the distance covered across the open field were observed to be slightly lesser than the rats that were pre-treated with baicalein. Rats that received baicalein at 50 and 100 mg presented behavioural responses similar to normal control rats ( Figure 6A ).
In the olfactory test, changes in the time consumed by the animals to find out the cheese buried inside was observed ( Figure 6B ).
Nevertheless, baicalein treated animals were able to trace out cheese very quick as compared to sevoflurane-alone exposed animals.
To evaluate the influence of baicalein on long-term recall following sevoflurane on P7, the P45 rats were exposed to contextual/ cued fear conditioning. In the training sessions, the animals are exposed to white noise (neutral auditory cues) and electric foot shock (context). represents mean values from different experimental groups that differ at p < 0.05 as derived by one-way ANOVA and DMRT analysis.
every training session, there were not many differences in the escape latency between various experimental groups ( Figure 7A ).
Nevertheless, rats exposed to sevoflurane alone presented slight dissimilarities from the animals that received baicalein and exposed to sevoflurane on P7.
The cued and place trials were directed to assess spatial navigation skills and visual abilities. The P45 rats that were subjected to sevoflurane anesthesia on P7 were found to take significantly a much-extended time to reach the underwater platform as against the rats that received no anesthesia ( Figure 7B ). Baicalein supplementation at 50 and 100 mg was found to improve the performance of the rats. The rats were able to identify the cue (rod) and also able to navigate faster to reach the platform.
Further, 100 mg baicalein gave the determined enhancement in the performance of the rats.
The ability of retaining memory was evaluated by probe trials wherein the platform was removed from target quadrant and was placed in a random quadrant. Capability to look out for the submerged platform in the target quadrant was detected. Sevoflurane exposure on P7 had substantially affected the memory of rats. The animals exposed to sevoflurane alone spent significantly lesser time in the target quadrant as compared to animals of the control group and baicalein treated groups. These results suggest that baicalein administration remarkably improved memory of the rats.
The 100 mg dose of baicalein presented more enhanced performance than the lower doses.
Further similar to results of fear conditioning tests and general behavioural analysis, baicalein at 50 mg or 100 mg given alone had no adverse effects on the behaviour and learning of rats. The responses observed were almost comparable to normal control rats.
Discussion
Sevoflurane has been reported to exert neurotoxic effects to the developing brain [1, 7] and also cause cognitive deficits [3] . In this study investigation was done to determine whether baicalein was able to attenuate sevoflurane-induced toxicity at doses of 25, 50 or 100 mg. Several studies have described that the expression of Bcl-2 family proteins is controlled by JNK [33] and ERK signalling [34] . JNK signalling helps apoptosis via transcriptional regulation of Bcl-2 family proteins [35] .
Activated JNK phosphorylates c-Jun that leads to rise of AP-1 transcription action and regulated transcription of genes of apoptotic pathway [30] . Further, Bcl-2 is constitutively phosphorylated by ERK1/2 [34] . Additionally, ERK1/2 directly phosphorylates pro-caspase-9 subsequently inhibiting caspase-3 activation [36] . Enhanced JNK signalling and supressed ERK1/2 in the P7 rats following sevoflurane Several experimental studies have shown that PI3K/Akt pathway plays a pivotal role in neurite initiation, growth and stability [6] .
Earlier reports have showed inactivation of Akt during apoptosis [28] and sevoflurane inhibit GSK-3β phosphorylation [37] . Sevoflurane exposure for 6 h reduced phosphorylation of Akt and GSK-3β. It is known that phosphorylation of Akt suppresses caspases [38] and inactivates Bad that causes release of Bcl-xL thus promoting cell survival [39] . In our study, baicalein administration significantly enhanced phosphorylation of Akt and GSK-3β and supressed PTEN, the negative regulator of the pathway [40] . Also, interestingly, we noticed 50mg dose of baicalein caused more markedly elevated expressions of total Akt, p-AKT, GSK-3β and p-GSK-3β as compared to 100 mg doses. Considering these observations, the effects of doses between 50 and 100 mg could be investigated to understand the effectiveness. Further, baicalein enhanced expression of other down-stream molecules of Akt such as cyclin D1, IκBα nuclear factor-κB (NF-κB). xIAP, cIAP-1 and survivin the important target genes of NF-κB [41] . It has been reported that GSK-3β causes activation of NF-κB [40] . 
Conclusion
The study data reveals the efficacy of baicalein in inhibition of neonatal sevoflurane-induced neuroapoptosis and neurobehavioral dysfunctions. Baicalein could be explored further in therapy against inhalation anestheticinduced neurotoxicities.
